| VX-702 |
ENSG00000117242.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000136315.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000146666.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000152487.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000167117.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000167912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000167912.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000170590.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000170919.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000172250.10 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000175873.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000177133.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000177369.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000177757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000178977.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000180139.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000180846.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000181798.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000182310.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000184324.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000185186.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000185433.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000187229.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000187229.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000188206.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000188660.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000188825.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000189149.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000189196.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000197332.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000197463.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000198106.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000203258.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000203288.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000203321.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000203321.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000203327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000203356.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000203441.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000203496.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000203588.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000203706.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000203801.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000203875.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000204011.4 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000204044.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000204625.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000204949.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000205054.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000205293.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000206567.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000213468.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000214559.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000214837.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000214955.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000215039.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000215068.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000215159.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000215304.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000215386.6 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000215424.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000215447.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000215483.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000215692.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000215808.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000215859.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000215866.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000218018.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000220161.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000221817.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000222041.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000223356.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000223373.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000223382.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000223382.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000223525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000223660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000223704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000223714.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000223732.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000223749.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000223749.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000223768.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000223774.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000223813.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000223821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000223839.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000223882.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000223930.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000223969.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000223969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000223975.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000224020.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000224043.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224078.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000224107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000224167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000224356.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000224358.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224481.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000224490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224511.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000224533.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000224549.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000224577.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000224592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000224596.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000224635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000224635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224638.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000224848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000224848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000224871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000224875.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000224905.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000224985.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000224992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000225075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000225083.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000225111.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000225138.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000225210.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000225213.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000225331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000225361.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000225393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000225393.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000225532.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000225548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000225643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000225762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000225762.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000225798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000225806.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000225806.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000225822.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000225886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000225889.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000225891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000225891.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000225913.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000225948.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000225952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000225953.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000225964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000225964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000226017.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000226047.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000226067.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000226194.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000226194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000226266.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000226276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000226281.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000226334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000226367.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000226367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000226465.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000226472.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000226472.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000226476.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000226496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000226548.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000226637.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000226669.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000226690.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000226716.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000226754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000226797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000226851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000226852.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000226856.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000226963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000227006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000227060.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000227066.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000227070.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000227155.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000227161.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000227218.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000227245.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000227388.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000227398.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000227456.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000227481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000227486.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000227487.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000227492.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000227495.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000227527.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000227540.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000227637.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000227673.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000227674.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000227681.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000227811.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000227838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000227857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000227888.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000227963.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000228010.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000228013.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000228106.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000228113.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000228150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000228223.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000228237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000228274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000228288.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000228350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000228369.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000228386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000228423.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000228444.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000228486.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000228526.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000228544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000228614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000228614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000228677.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000228686.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000228775.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000228793.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000228794.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000228857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000228956.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000228988.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000229021.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000229111.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000229127.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000229137.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000229140.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000229152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000229195.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000229278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000229291.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000229348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000229356.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000229382.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000229388.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000229444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000229463.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000229484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000229582.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000229645.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000229739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000229807.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000229891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000229901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000229955.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000229956.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000229989.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000230013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000230021.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000230058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000230131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000230174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000230300.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000230310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000230316.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000230424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000230439.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000230555.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000230735.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000230736.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000230747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000230751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000230753.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000230798.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000230812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000230825.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000230836.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000230838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000230894.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000230898.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000230914.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000230914.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000230925.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000230990.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000231024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000231028.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000231081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000231092.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000231104.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000231154.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000231217.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000231305.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000231346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000231486.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000231551.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000231563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000231563.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000231563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000231595.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000231663.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000231666.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000231709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000231724.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000231731.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000231734.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000231769.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000231795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000231806.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000231826.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000231865.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000231881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000231920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000231992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000232063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232063.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000232065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000232065.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000232093.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000232104.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232110.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232116.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000232164.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000232233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000232274.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000232290.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000232453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000232453.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000232458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000232519.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000232536.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000232545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000232593.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232648.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232684.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000232692.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000232712.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232811.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000232827.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000232891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000232892.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000232907.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000232913.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000232969.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000232977.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000233006.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000233013.4 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000233029.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000233077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000233154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233223.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000233244.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233251.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233360.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000233396.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000233427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000233501.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000233532.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000233590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000233613.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000233621.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000233643.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000233723.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233757.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233785.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000233791.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000233806.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000233858.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000233860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000233862.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000233885.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000233930.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000233937.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000234019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000234062.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000234084.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000234134.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000234160.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000234181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000234197.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000234323.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000234327.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000234336.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000234350.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000234418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000234428.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000234453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000234494.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000234509.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000234520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000234535.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000234546.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000234584.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000234584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000234650.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000234698.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000234754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000234869.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000234869.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000234899.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000234945.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000235021.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000235033.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000235072.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000235077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000235119.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235138.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000235246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000235257.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000235298.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235314.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000235326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000235326.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235398.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000235398.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235423.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000235426.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000235437.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235437.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000235475.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235481.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000235530.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000235545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000235565.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000235586.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000235597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000235609.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000235609.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235652.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000235664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000235760.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000235770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000235802.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000235831.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000235837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000235880.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000235902.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000235947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000235949.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000235999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000236021.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000236051.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000236065.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000236194.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000236206.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000236262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000236299.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000236364.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000236383.3 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000236404.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000236404.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000236432.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000236472.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000236498.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000236519.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000236519.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000236545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000236545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000236546.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000236618.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000236703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000236743.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000236772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000236778.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000236780.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000236810.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000236830.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000236871.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000236896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000236901.3 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000236943.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000237073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000237087.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000237126.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000237187.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000237188.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000237234.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000237336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000237338.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000237359.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000237438.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000237476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000237489.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000237505.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000237505.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000237517.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000237525.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000237637.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000237689.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000237718.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000237737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000237738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000237751.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000237753.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000237773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000237798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000237819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000237819.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000237845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000237852.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000237879.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000237927.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000237940.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000237945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000238005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000238058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000238062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000238123.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000238123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000238141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000238160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000238197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000238197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000238279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000238280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000238280.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000238290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000239002.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000239213.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000239219.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000239593.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000239664.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000239774.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000239828.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000239911.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000239911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000239920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000239920.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000239930.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000240032.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000240093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000240449.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000240687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000241163.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000241316.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000241520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000241679.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000241732.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000241772.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000241860.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000241886.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000241954.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000241954.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000241990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000242628.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000242759.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000242808.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000242808.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000243069.3 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000243069.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000243230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000243433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000243433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000243701.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000243885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000243926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000244184.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000244310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000244345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000244345.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000244468.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000244676.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000244952.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000244998.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000245060.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000245149.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000245522.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000245598.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000245694.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000245729.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000245975.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000246225.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000246308.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000246323.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000246323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000246448.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000246528.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000246582.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000246627.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000246731.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000246740.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000246851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000246859.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000246863.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000246877.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000247137.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000247151.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000247157.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000247317.3 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000247373.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000247675.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000247679.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000247775.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000247796.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000247809.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000248027.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000248079.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000248079.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000248103.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000248143.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000248323.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000248399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000248456.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000248468.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000248514.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000248544.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000248668.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000248671.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000248693.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000248740.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000248787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000249084.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000249159.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000249216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000249216.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000249249.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000249293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000249304.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000249345.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000249412.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000249413.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000249492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000249502.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000249526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000249532.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000249593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000249593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000249602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000249609.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000249631.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000249731.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000249740.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000249753.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000249859.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000249911.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000250012.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000250027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000250027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000250057.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000250101.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000250129.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000250132.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000250132.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000250155.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000250156.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000250170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000250192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000250240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000250258.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000250303.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000250303.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000250303.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000250312.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000250410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000250602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000250629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000250629.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000250786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000250790.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000250842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000250893.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000250903.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000250938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000250950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000250986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000250988.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000251003.3 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000251022.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000251131.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000251143.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000251152.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000251445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000251600.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000251602.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000251604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000253116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000253133.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000253214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000253302.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000253327.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000253355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000253355.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000253392.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000253430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000253444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000253476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000253515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000253535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000253552.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000253567.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000253591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000253616.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000253641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000253671.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000253678.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000253696.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000253737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000253741.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000253825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000253829.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000253837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000253854.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000253875.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000253875.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000253878.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000253878.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000253948.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000253986.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000254039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000254057.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000254180.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254223.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000254231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000254258.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000254267.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000254288.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000254333.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000254340.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000254340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000254343.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254391.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000254416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000254468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000254484.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254539.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254551.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000254554.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000254561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000254604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000254607.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000254615.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000254662.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000254689.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000254689.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000254699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000254718.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000254837.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000254859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000254860.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000254879.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000254910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000255050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000255084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000255089.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000255090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255148.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000255160.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255229.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000255234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000255234.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000255240.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255241.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255310.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000255318.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000255345.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000255362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000255367.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000255495.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000255495.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000255670.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000255774.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000255843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000255970.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000256020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000256092.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000256124.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000256151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000256237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000256325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000256448.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000256481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000256588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000256705.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000256721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000256742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000256751.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000256789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000256982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000257027.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000257038.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000257135.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000257167.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000257176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000257193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000257221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000257261.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000257354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000257475.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000257507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000257534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000257568.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000257596.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000257636.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000257642.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000257642.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000257647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000257718.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000257824.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000257947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000257999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000258096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000258101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258137.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000258168.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000258260.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000258302.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000258325.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000258334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000258428.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000258455.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000258515.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000258520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000258545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258558.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000258663.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000258701.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000258704.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258711.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000258733.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000258789.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000258815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000258821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258831.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000258904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000258935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000258942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000258952.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000259067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000259146.2 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000259177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000259209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000259254.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259287.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259310.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000259319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000259319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259319.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000259353.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000259364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000259376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000259380.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000259408.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259417.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000259418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000259448.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000259453.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000259463.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000259488.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000259515.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259523.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000259542.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000259561.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000259577.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000259577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000259595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000259617.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259628.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000259645.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000259672.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000259673.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000259676.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000259687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000259709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000259760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000259762.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000259763.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000259768.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000259782.2 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000259799.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000259863.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000259899.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000259974.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000260095.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000260136.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000260160.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000260167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260194.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000260196.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000260252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260285.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000260329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260351.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000260394.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260409.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000260425.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000260436.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000260436.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000260447.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260447.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000260493.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000260515.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000260526.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000260528.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000260579.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000260597.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000260601.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000260608.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000260626.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000260650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000260671.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000260672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000260693.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000260708.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000260744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000260774.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000260830.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000260853.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000260855.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000260910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000260924.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000260932.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000260977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000260986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000261064.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000261069.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261131.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000261135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000261195.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000261200.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261253.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000261266.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000261318.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000261369.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261431.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000261442.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000261451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000261485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000261534.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000261574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261582.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000261610.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000261634.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000261644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000261685.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000261712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000261723.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000261737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261780.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000261780.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000261786.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000261827.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000261840.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000261864.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000261872.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000261916.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000261924.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000262117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000262136.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000262185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000262202.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000262223.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000262312.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000262372.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000262380.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000262482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000262580.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000262678.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000262823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000262837.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000262903.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000262951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000263063.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000263098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000263154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000263207.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000263220.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000263272.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000263280.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000263327.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000263680.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000263843.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000264043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000264078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000264196.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000264207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000264270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000264448.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000264630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000264672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000264672.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000264673.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000264729.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000264853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000264932.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000264937.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000265091.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000265218.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000265334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000265334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000265443.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000265445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000265519.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000265542.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000265739.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000265800.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000265845.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000265908.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000265912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000265912.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000265943.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000266126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000266278.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000266283.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000266289.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000266313.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000266313.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000266445.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000266456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000266579.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000266644.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000266654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000266664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000266821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000266824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000266850.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000266900.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000266911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000266913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000266918.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000266922.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000266927.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000266934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000266941.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000266993.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000266999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000267002.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000267115.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267141.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000267151.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000267161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000267192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000267197.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000267198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000267201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000267246.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000267304.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267321.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000267345.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000267347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000267347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000267374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000267388.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000267437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000267449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000267449.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000267474.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000267481.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000267493.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000267565.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267567.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000267606.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000267638.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000267649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000267666.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267703.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000267734.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000267737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000267750.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000267762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000267776.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000267786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267798.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000267838.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000267838.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000267858.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000267919.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000267924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000267927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000267940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000268015.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000268095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000268186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000268266.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000268340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000268364.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000268520.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000268568.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000268584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000268670.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000268670.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000268751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000268945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000268947.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000269019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000269082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000269148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000269161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000269161.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000269177.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000269246.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000269289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000269321.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000269489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000269652.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000269656.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000269680.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000269694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000269696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000269806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000269814.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000269815.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000269834.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000269873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000269895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000269924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000269938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000269951.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000269951.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000269976.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000269983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000269986.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000269997.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000270020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000270022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000270028.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000270066.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000270068.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000270091.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000270104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000270110.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000270117.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000270157.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000270174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000270177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000270190.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000270332.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000270332.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000270346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000270462.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000270522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000270604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000270607.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000270640.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000270641.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000270673.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000270704.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000270720.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000270876.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000270972.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000270996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000271109.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000271119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000271172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000271218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000271347.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000271576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271590.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000271734.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271738.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000271762.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000271874.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000271888.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000271926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000271948.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000271978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000271998.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000272070.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000272128.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000272142.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000272158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000272181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272191.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000272217.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000272235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272369.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000272411.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000272425.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000272455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000272459.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000272462.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000272462.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272468.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000272483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272518.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000272558.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272562.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272562.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000272576.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000272588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000272609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000272650.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000272657.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272682.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000272696.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000272709.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000272709.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000272716.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000272745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000272748.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000272761.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000272769.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000272789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000272795.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272799.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000272810.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272870.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000272904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000272905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000272966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000273001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273011.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000273033.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000273061.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000273069.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000273071.1 |
Predicted lncRNA |
Sarcoma |
|
| VX-702 |
ENSG00000273075.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000273108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273113.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000273123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000273129.1 |
Predicted lncRNA |
Esophageal cancer |
|
| VX-702 |
ENSG00000273148.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273165.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000273186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273232.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000273267.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000273267.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| VX-702 |
ENSG00000273272.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000273289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000273297.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000273321.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| VX-702 |
ENSG00000273367.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000273368.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| VX-702 |
ENSG00000273369.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| VX-702 |
ENSG00000273374.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000273381.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| VX-702 |
ENSG00000273381.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| VX-702 |
ENSG00000273381.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| VX-702 |
ENSG00000273454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| VX-702 |
ENSG00000273473.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| VX-702 |
ENSG00000273486.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
